Urticarial Vasculitis

Cure Arthritis Naturally

Beat Arthritis Naturally

Get Instant Access

Urticarial vasculitis is usually an acquired idiopathic phenomenon but may also occur in association with other disorders, such as SLE or Sjogren's syndrome (Davis et al., 1998; Sanchez et al., 1982;

Mehregan et al., 1992; O'Loughlin et al., 1978;, Provost et al., 1980). All of the patients reported with urticarial vasculitis in association with SLE have shown varying combinations of multisystem disease, and two forms of urticarial vasculitis have been described (Provost, 2004). The most common form, occurring in approximately 10% of patients with SLE, is associated with various autoantibodies (anti-dsDNA, anti-Ro/SSA, and anti-U1RNP antibodies) and, furthermore, these patients show a systemic disease, including glomerulonephritis and arthritis. Most of these patients also demonstrate a leukocytoclastic angiitis and, in some cases, a mono-nuclear vasculopathy has been described. The second form of urticarial vasculitis seen in patients with SLE is characterized by the presence of anti-C1q antibodies and hypocomplementemia. This form of urticarial vasculitis can also occur in patients without SLE and is termed hypo-complementemic urticarial vasculitis (HUVS) (Uwatoko and Mannik, 1988). Clinically, these patients frequently demonstrate arthralgias, arthritis, glomerulonephritis, angioedema, ocular inflammation (conjunctivitis, episcleritis, uveitis, etc.), and obstructive lung disease.

Urticarial vasculitis has usually a chronic course lasting for years; however, complete resolution of the skin lesions has also been described. The urtic-arial skin lesions are characterized as transient, well-circumscribed, edematous, lightly erythematous wheals, often with central clearing or a peripheral halo. However, the individual lesions usually persist for 24 h or longer. Occasionally, these lesions resolve with secondary changes, e.g. pigmentation, scaling, or purpura. With regard to symptoms, some patients complain of burning or painful lesions as opposed to pruritic lesions of classic urticaria. The typical histologic feature is a fibrinoid necrotizing vasculitis in the upper dermis, with leukocytoclasis and erythrocyte diapedesis. Direct immunofluores-cence of urticarial lesions demonstrates various combinations of immunoglobulins and complement components in the vessels walls.

3.3. Papulonodular mucinosis

Mucin deposition is generally restricted to primary mucinoses, such as lichen myxedematosus, and is rarely present in sufficient quantity to produce lesions that are clinically detectable in other diseases, such as LE (Kanda et al., 1997). Although recognized as early as 1954 by Gold (1954), only approximately 40 patients with papulonodular mucinosis associated with various forms of LE have been described in the literature (Sonntag et al., 2003; Hazan, 2004; Ortiz et al., 2004). In most cases, papulonodular mucinosis is associated with SLE, but can also be found in patients with DLE and SCLE. Interestingly, it has been indicated that papulonodular mucinosis tends to occur more frequently in males, indicating a possible role for sex-related factors, such as androgenic hormones, in the pathogenesis of this associated disease (Kanda et al., 1997). In addition, exposure to sunlight may be a further contributing factor in the pathogenesis of papulonodular mucinosis (Nagy et al., 1967; Moulin et al., 1980; Weidner and Djawari, 1982; Sonntag et al., 2003).

Clinically, papulonodular mucinosis presents with asymptomatic skin-colored papules and nodules that can be seen inside and outside of typical lesions of LE and involve mostly the trunk and upper extremities, but the face and other locations can also be affected. In some patients, papulonod-ular mucinosis predates LE, and in others it is associated with its activity, and it can even be the only cutaneous manifestation of LE during a period of time (Sonntag et al., 2003). The histologic picture of papulonodular mucinosis is dominated by abundant interstitial mucin deposition in the papillary and reticular dermis, which can be confirmed by colloidal iron staining, and there is also a mild superficial perivascular lymphocytic infiltrate. However, the characteristic alterations of LE, such as epidermal involvement and vacuolar degeneration of the dermoepidermal junction, are absent (Kanda et al., 1997; Weigand et al., 1981).

Several cutaneous mucinoses might lead to diagnostic confusion with papulonodular mu-cinosis, including lichen myxedematosus, reticular erythematosus mucinosis, and pretibial or generalized myxedema (Reed et al., 1973; Rongio-letti and Rebora, 1991, 2001). Lichen myxede-matosus most likely bears striking similarities to papulonodular mucinosis, but the clinical features differ in the form of the papules, which tend to be smaller, and the localization is most common on the face and arms.

3.4. Annular erythema

Annular erythema has been recognized as a cutaneous manifestation of Sjogren's syndrome in Asian patients and, in only one case report, it has been described in a white female (Haimowitz et al., 2000; Watanabe et al., 1997; Teramoto et al., 1989). However, in certain cases it can also represent an unusual skin manifestation within the spectrum of LE (Kuhn et al., 2000b; Ruzicka et al., 1991). Since there are common pathophysiologic mechanisms, mainly the presence of anti-Ro/SSA or anti-La/SSB antibodies, it is in some cases difficult to separate annular erythema from SCLE. However, more recent studies demonstrated that annular erythema associated with Sjogren's syndrome can clinically and histologically be differentiated from SCLE and that HLA-DRw52/-Cw3 is closely related to patients with annular erythema (Hoshino et al., 1992; Katayama et al., 1991, 1994; Miyagawa, 1994; Provost et al., 1988a; Watanabe et al., 1997).

Clinically, annular erythema is characterized by erythematous papules and centrifugal extension leading to urticarial plaques with annular elevated borders and central hyperpigmentation. In majority of patients, the erythema appears symmetrically on the face, the trunk, or the extensor aspects of the extremities, but the entire integument may also be involved. Histologic investigation shows slight epidermal changes without dyskeratotic cells or follicular plugging and reveals no changes at the dermoepidermal junction. A lymphocyte infiltration around the blood vessels and a marked edema are seen in the papillary dermis. Additional studies demonstrated prominent mucin deposition in these lesions (Kuhn et al., 2000b; Nishikawa and Provost, 1991).

4. Conclusions

Cutaneous manifestations in patients with LE are very frequent, show a great variety and can occur at any stage of the disease. A classification system has been established dividing the skin lesions associated with LE in specific and non-specific manifestations. The non-specific manifestations such as urticaria vasculitis and annular erythema, are also seen in conditions other than LE and are thus not specific for this disease. Although the specific cutaneous manifestations of this disease are considered to have a less severe course and to carry a better prognosis than the systemic form, 67-70% of patients with SCLE and 14-27% of patients with DLE have extracutaneous signs (Tebbe and Orfanos, 1997). Patients who have a more generalized involvement of the skin tend to have more systemic symptoms than those with lesions localized to the face or neck. Nevertheless, all cutaneous manifestations of LE can result in limited patient quality of life and disability from work. It has also been found that 45% of patients with CLE experience some form of vocational handicap. However, recent epidemiological data of the cutaneous manifestations of LE are not available (Jimenez et al., 2004). Therefore, it has been a long standing need for a study group including experts of different medical specialities in order to better focus on all aspects related to LE. In 2004, the 'Interdisciplinary Study Group of Lupus Erythematosus (ISGLE)' was founded with the aims (i) to receive an overview of the spectrum of clinical and laboratory features and therapeutic strategies of this disease, (ii) to develop criteria for disease activity and diagnostic guidelines for patients with LE, and (iii) to implement evidence based management strategies and standards of care for patients with the various manifestations of this disease. Further aims of ISGLE are (i) continuous standardized evaluation of the different organ systems, (ii) continuous exchange between the involved specialists on problems of their patients (e.g., pregnancy); (iii) communication of early diagnosis and treatment as well as patient education improving the quality of life and the socioeconomic status of patients with LE (http:// www.ISGLE.rheumanet.org).

5. Acknowledgements

This work was supported by Heisenberg professorship from the German Research Association (DFG) to A.K. (KU 1559/1-1).

Key points

• The clinical expression of skin involvement in lupus erythematosus (LE) is very frequent and shows a great variety.

• Gilliam (1977) initially proposed a classification system for the skin lesions that can be encountered in patients with LE and divided the cutaneous manifestations of this disease into those that are histologically specific for LE (i.e., LE-specific skin disease) and those that are not histologically specific for this disease (i.e., LE-non-specific skin disease).

• In 2003, a modified classification system of cutaneous LE (CLE) has been developed including acute CLE, subacute CLE, chronic CLE, and the intermittent subtype of CLE, ICLE.

• Non-specific cutaneous manifestations of LE which can also occur in association with other disorders include non-scarring alopecia, annular erythema, calcinosis cutis, papulonodular mucinosis, rheumatoid nodules, and sclerodactyly. Furthermore, several skin diseases can also be found in the context of LE such as acanthosis nigricans, anetoderma, cutaneous vascular diseases, e.g., Raynaud's phenomenon and urticaria vasculitis, erythema multiforme, bullous autoimmune diseases, lichen planus, and porphyria cutanea tarda.


Alexiades-Armenakas, M.R., Baldassano, M., Bince, B., et al. 2003. Tumid lupus erythematosus: criteria for classification with immunohistochemical analysis. Arthritis Rheum. 5, 494. Andreasen, J.O., Poulsen, H.E. 1964. Oral discoid and sytemic lupus erythematosus. Acta Odont. Scand. 22, 289. Bacman, D., Ostendorf, B., Megahed, M., et al. 2004. Bullous systemic lupus erythematosus. Hautarzt. 55, 392. Bangert, J.L., Freemann, R.G., Sontheimer, R.D., et al. 1984. Subacute cutaneous lupus erythematosus and discoid lupus erythematosus. Comparative histopathologic findings. Arch. Dermatol. 120, 332. Barton, D.D., Fine, J.D., Gammon, W.R., et al. 1986. Bullous systemic lupus erythematosus: an unusual clinical course and detectable circulating autoantibodies to the epidermo-lysis bullosa acquisita antigen. J. Am. Acad. Dermatol. 16, 369.

Blanchet, P., Auffret, N., Fouchard, J., et al. 1981. Association of thymoma, superficial pemphigus, nephrotic syndrome and lupus biology. Ann. Dermatol. Venereol. 108, 471.

Botella, R., Alfonso, R., Silvestre, J., et al. 1999. Discoid lupus erythematosus-like lesions and stomatitis. Arch. Dermatol. 135, 847.

Braverman, I.M. 1981. Connective tissue (rheumatic) diseases. In: I.M. Braverman (Ed.), Skin Signs of Systemic Diseases. WB Saunders company, Philadelphia, p. 255.

Breathnach, S.M., Wells, G.C. 1979. Chilblain lupus erythe-matosus with response to chemical sympathectomy. Br. J. Dermatol. 101, 49.

Burge, S.M., Frith, P.A., Juniper, R.P., Wojnarowska, F. 1989. Mucosal involvement in systemic and chronic cutaneous lupus erythematosus. Br. J. Dermatol. 121, 727-741.

Callen, J.P., Klein, J. 1988. Subacute cutaneous lupus erythe-matosus. Clinical, serologic, immunogenetic, and therapeutic considerations in seventy-two patients. Arthritis Rheum. 31, 1007.

Callen, J.P., Kulick, K.B., Stelzer, G., et al. 1986. Subacute cutaneous lupus erythematosus. Clinical, serologic, and immunogenetic studies of forty-nine patients seen in a non-referral setting. J. Am. Acad. Dermatol. 15, 1227.

Camisa, C., Sharma, H.M. 1983. Vesicobullous systemic lupus erythematosus: report of two cases and a review of the literature. J. Am. Acad. Dermatol. 9, 924.

Cardinali, C., Caproni, M., Bernacchi, E., et al. 2000. The spectrum of cutaneous manifestations in lupus erythemato-sus—the Italian experience. Lupus 9, 417.

Cervera, R., Khamashta, M.A., Font, J., et al. 1993. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) 72, 113.

Chan, L.S., Lapiere, J.C., Chen, M., et al. 1999. Bullous systemic lupus erythematosus with autoantibodies recognizing multiple skin basement membrane components, bullous pe-mphigoid antigen 1, laminin-5, laminin-6, and type VII collagen. Arch. Dermatol. 135, 569.

Chlebus, E., Wolska, H., Blaszczyk, M., et al. 1998. Subacute cutaneous lupus erythematosus versus systemic lupus ery-thematosus: diagnostic criteria and therapeutic implications. J. Am. Acad. Dermatol. 38, 405.

Choonhakarn, C., Poonsriaram, A., Chaivoramukul, J. 2004. Lupus erythematosus tumidus. Int. J. Dermatol. 43, 815.

Chorzelski, T., Jablonska, S., Blaszczyk, M. 1968. Immuno-pathological investigations in the Senear-Usher syndrome (coexistence of pemphigus and lupus erythematosus). Br. J. Dermatol. 80, 211.

Cohen, L.M., Tyring, S.K., Rady, P., et al. 1992. Human pap-illomavirus type 11 in multiple squamous cell carcinomas in a patient with subacute cutaneous lupus erythematosus. J. Am. Acad. Dermatol. 26, 840.

Cohen, M.R., Crosby, D. 1994. Systemic disease in subacute cutaneous lupus erythematosus: a controlled comparison with systemic lupus erythematosus. J. Rheumatol. 21, 1665.

Costner, M.I., Sontheimer, R.D., & Provost, T.T. 2003. Lupus erythematosus. In: R.D. Sontheimer, & T.T. Provost (Eds.), Cutaneous Manifestations of Rheumatic Diseases. Williams & Wilkins, Philadelphia, p. 15.

Cutaneous Manifestations of Rheumatic Diseases is a clinical reference for dermatologists and rheumatologists with colour representations and comprehensive discussions of the various clinical manifestations of rheumatic diseases.

Crowson, A.N., Magro, C. 2001. The cutaneous pathology of lupus erythematosus: a review. J. Cutan. Pathol. 28, 1.

Daldon, P.E., Macedo de Souza, E., Cintra, M.L. 2003. Hyper-trophic lupus erythematosus: a clinicopathological study of 14 cases. J. Cutan. Pathol. 30, 443.

David, K.M., Thornton, J.C., Davis, B., et al. 1984. Morbidity and mortality in patients with subacute cutaneous lupus erythematosus (SCLE). J. Invest. Dermatol. 82, 408.

David-Bajar, K.M. 1993. What's new in cutaneous lupus syndromes: subacute cutaneous lupus erythematosus. J. Invest. Dermatol. 100, 2S.

David-Bajar, K.M., Davis, B.M. 1997. Pathology, immunopa-thology, and immunohistochemistry in cutaneous lupus erythematosus. Lupus 6, 145.

Davies, M.G., Marks, R., Waddington, E. 1976. Simultaneous systemic lupus erythematosus and dermatitis herpetiformis. Arch. Dermatol. 112, 1292.

Davis, M.D., Daoud, M.S., Kirby, B., et al. 1998. Clinico-pathologic correlation of hypocomplementemic and norm-ocomplementemic urticarial vasculitis. J. Am. Acad. Dermatol. 38, 899.

Dekle, C.L., Mannes, K.D., Davis, L.S., et al. 1999. Lupus tumidus. J. Am. Acad. Dermatol. 41, 250.

DeSpain, J.D., Clark, D.P. 1988. Subacute cutaneous lupus erythematosus presenting as erythroderma. J. Am. Acad. Dermatol. 19, 388.

Dotson, A.D., Raimer, S.S., Pursley, T.V., et al. 1981. Systemic lupus erythematosus occurring in a patient with epidermo-lysis bullosa acquisita. Arch. Dermatol. 117, 422.

Doutre, M.S., Beylot, C., Beylot, J., et al. 1992. Chilblain lupus erythematosus: report of 15 cases. Dermatology 184, 26.

Eckman, J.A., Mutasim, D.F. 2002. Bullous systemic lupus erythematosus with milia and calcinosis. Cutis 70, 31.

Fabbri, P., Bernacchi, E., Neri, R. 1990. Subacute cutaneous lupus erythematosus. Review of the literature and immu-nological studies of 11 patients. G. Ital. Dermatol. Venereol. 125, 329.

Fabbri, P., Cardinali, C., Giomi, B., Caproni, M. 2003. Cutaneous lupus erythematosus: diagnosis and management. Am. J. Clin. Dermatol. 4, 449-465.

Fisher, D.A., Everett, M.A. 1996. Violaceous rash of dorsal fingers in a woman. Diagnosis: chilblain lupus erythemato-sus (perniosis). Arch. Dermatol. 132, 459.

Franke, W., Kuhn, A., Megahed, M., et al. 1999. Periorbital edema as the initial symptom of lupus erythematosus profundus. Case report and discussion of the literature. Hautarzt 50, 889.

Gammon, W.R., Briggaman, R.A. 1993. Bullous SLE: a pheno-typically distinctive but immunologically heterogeneous bullous disorder. J. Invest. Dermatol. 100, 28S.

Gammon, W.R., Woodley, D.T., Dole, K.C., et al. 1985. Evidence that anti-basement membrane zone antibodies in bullous eruption of systemic lupus erythematosus recognize epidermolysis bullosa acquisita autoantigen. J. Invest. Der-matol. 84, 472.

Gilliam, J.N. 1977. The cutaneous signs of lupus erythemato-sus. Cont. Educ. Fam. Phys. 6, 34.

Gilliam, J.N., Sontheimer, R.D. 1981. Distinctive cutaneous subsets in the spectrum of lupus erythematosus. J. Am. Acad. Dermatol. 4, 471.

Gilliam, J.N., Sontheimer, R.D. 1982. Subacute cutaneous lupus erythematosus. Clin. Rheum. Dis. 8, 343.

Goerz, G., Lehmann, P., Schuppe, H.C., et al. 1990. Lupus erythematosus. Z. Hautkr. 65, 226.

Gold, S.C. 1954. An unusual papular eruption associated with lupus erythematodes. Br. J. Dermatol. 66, 429.

Grant, J.M. 1981. Annular vesicular lupus erythematosus. Cutis 28, 90.

Haimowitz, J.E., McCauliffe, D.P., Seykora, J., et al. 2000. Annular erythema of Sjogren's syndrome in a white woman. J. Am. Acad. Dermatol. 42, 1069.

Hall, R.P., Lawley, T.J., Smith, H.R., et al. 1982. Bullous eruption of systemic lupus erythematosus. Ann. Intern. Med. 97, 165.

Hazan, C. 2004. Papulonodular mucinosis with subacute cutaneous lupus erythematosus. Dermatol. Online J. 10, 6.

Helm, T.N., Jones, C.M. 2002. Chilblain lupus erythematosus lesions precipitated by the cold. Cutis 69, 183-184.

Herrero, C., Bielsa, I., Font, J., et al. 1988. Subacute cutaneous lupus erythematosus: clinicopathologic findings in thirteen cases. J. Am. Acad. Dermatol. 19, 1057.

Hoshino, Y., Hashimoto, T., Mimori, T., et al. 1992. Recurrent annular erythema associated with anti-SS-B/La antibodies: analysis of the disease-specific epitope. Br. J. Dermatol. 127, 608.

Hutchinson, J. 1888. Harveian lectures on lupus. Lecture III. On the various form of lupus vulgaris and erythematosus. Br. Med. J. 1, 113.

Hymes, S.R., Jordon, R.E. 1989. Chronic cutaneous lupus erythematosus. Med. Clin. North. Am. 73, 1055.

Irgang, S. 1940. Lupus erythematosus profundus. Arch. Dermatol. Syph. 42, 97.

Jimenez, S., Cervera, R., Ingelmo, M., et al. 2004. The epidemiology of lupus erythematosus. In: A. Kuhn, P. Lehmann, T. Ruzicka (Eds.), Cutaneous Lupus Erythematosus. Springer, Heidelberg, pp. 33-44.

Jolly, M., Laumann, A.E., Shea, C.R., et al. 2004. Lupus ery-thematosus tumidus in systemic lupus erythematosus: novel association and possible role of early treatment in prevention of discoid lupus erythematosus. Lupus 13, 64.

Kanda, N., Tsuchida, T., Watanabe, T., et al. 1997. Cutaneous lupus mucinosis: a review of our cases and the possible pathogenesis. J. Cutan. Pathol. 24, 553.

Kanwar, J., Dhar, S., Ghosh, S. 1993. Involvement of nails in discoid lupus erythematosus. J. Assoc. Phys. India 41, 543.

Kaposi, M.K. 1883. Pathologie und Therapie der Hautkrankheiten. Urban and Schwarzenberg, Wien, p. 642.

Katayama, I., Teramoto, N., Arai, H., Nishioka, K., Nishi-yama, S. 1991. Annular erythema. A comparative study of Sjogren syndrome with subacute cutaneous lupus erythe-matosus. Int. J. Dermatol. 30, 635.

Katayama, I., Yamamoto, T., Otoyama, K., et al. 1994. Clinical and immunological analysis of annular erythema associated with Sjogren syndrome. Dermatology 189, 14.

Kossard, S. 2002. Lupus panniculitis clinically simulating alopecia areata. Australas. J. Dermatol. 43, 221.

Kuhn, A., Ruzicka, T. 2004. Classification of cutaneous lupus eyrthematosus. In: A. Kuhn, P. Lehmann, T. Ruzicka (Eds.), Cutaneous Lupus Erythematosus. Springer, Heidelberg, pp. 53-58.

Kuhn, A., Beissert, S. 2005. Photosensitivity in lupus erythe-matosus. Autoimmunity, in press.

Kuhn, A., Richter-Hintz, D., Oslislo, C., et al. 2000a. Lupus erythematosus tumidus—a neglected subset of cutaneous lupus erythematosus: report of 40 cases. Arch. Dermatol., 136, 1033.

Clinical, histologic, and laboratory features of 40 patients with LET were analyzed and diagnositic criteria were established to differentiate this subtype from other skin disorders.

Kuhn, A., Richter-Hintz, D., Schuppe, H.C., et al. 2000b. Annular erythema in Sjogren syndrome. A variant of cutaneous lupus erythematosus?. Hautarzt. 51, 270.

Kuhn, A., Schuppe, H.C., Ruzicka, T., et al. 2000c. Seltene kutane Manifestationsformen des Lupus erythematodes. Hautarzt. 51, 818.

Kuhn, A., Sonntag, M., Richter-Hintz, D., et al. 2001a. Pho-totesting in lupus erythematosus: a 15-year experience. J. Am. Acad. Dermatol. 45, 86.

Kuhn, A., Sonntag, M., Richter-Hintz, D., et al. 2001b. Photo-testing in lupus erythematosus tumidus—review of 60 patients. Photochem. Photobiol. 73, 532.

Kuhn, A., Sonntag, M., Lehmann, P., et al. 2002a. Characterization of the inflammatory infiltrate and expression of endothelial cell adhesion molecules in lupus erythematosus tu-midus. Arch. Dermatol. Res. 294, 6.

Kuhn, A., Sonntag, M., Sunderkotter, C., et al. 2002b. Upreg-ulation of epidermal surface molecule expression in primary and ultraviolet-induced lesions of lupus erythematosus tu-midus. Br. J. Dermatol. 146, 801.

Kuhn, A., Sonntag, M., Ruzicka, T., et al. 2003. Histopathologic findings in lupus erythematosus tumidus: review of 80 patients. J. Am. Acad. Dermatol. 48, 901.

Kuhn, A., Sontheimer, R.D., Ruzicka, T. 2004. Clinical manifestations of cutaneous lupus erythematosus. In: A. Kuhn,

P. Lehmann, T. Ruzicka (Eds.), Cutaneous Lupus Erythematosus. Springer, Heidelberg, p. 59.

Cutaneous Lupus Erythematosus is based on multidiscipli-nary knowledge and is written by leading clinicians and scientists providing a comprehensive description of the classification and clinical aspects, pathogenesis, treatment and management of CLE.

Lapiere, J.C., Woodley, D.T., Parente, M.G., et al. 1993. Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa. J. Clin. Invest. 92, 1831.

Lau, M., Kaufmann-Grunzinger, I., Raghunath, M. 1991. A case report of a patient with features of systemic lupus erythe-matosus and linear IgA disease. Br. J. Dermatol. 124, 498.

Lodi, A., Pozzi, M., Agostoni, A., et al. 1993. Unusual onset of lupus erythematosus profundus. Br. J. Dermatol. 129, 96.

Lyon, C.C., Blewitt, R., Harrison, P.V. 1998. Subacute cutaneous lupus erythematosus: two cases of delayed diagnosis. Acta Derm. Venereol. 78, 57.

Magee, K.L., Hymes, S.R., Rapini, R.P., et al. 1991. Lupus erythematosus profundus with periorbital swelling and proptosis. J. Am. Acad. Dermatol. 24, 288.

Martens, P.B., Moder, K.G., Ahmed, I. 1999. Lupus pan-niculitis: clinical perspectives from a case series. J. Rheum-atol. 26, 68.

Mascaro, J.M., Herrero, C., Hausmann, G. 1997. Uncommon cutaneous manifestations of lupus erythematosus. Lupus 6, 122.

McCauliffe, D.P. 2001. Cutaneous lupus erythematosus. Semin. Cutan. Med. Surg. 20, 14.

Megahed, M. 2004. Bullous systemic lupus erythematosus. In: M. Megahed (Ed.), Histopathology of Blistering Disaeses with Clinical, Electron Microscopic, Immunological, and Molecular Biological Correlations. Springer, Berlin, Heidelberg, New York, p. 236.

Mehregan, D.R., Hall, M.J., Gibson, L.E. 1992. Urticarial vasculitis: a histopathologic and clinical review of 72 cases. J. Am. Acad. Dermatol. 26, 441.

Milde, P., Goerz, G. 1994. Depigmentierung bei Lupus erythematodes (LE)—Klinischer "Clue" zum subakut kutanen Lupus erythematodes (SCLE). Z. Hautkr. 69, 123.

Miller, J.F., Downham, T.F., Chapel, T.A. 1978. Coexistent bullous pemphigoid and systemic lupus erythematosus. Cutis 21, 368.

Miyagawa, S. 1994. Clinical, serological and immunogenetic features of Japanese anti-Ro/SS-A-positive patients with annular erythema. Dermatology 189, 11.

Molad, Y., Weinberger, A., David, M., et al. 1987. Clinical manifestations and laboratory data of subacute cutaneous lupus erythematosus. Isr. J. Med. Sci. 23, 278.

Moulin, G., Bouchet, B., Souteyrand, P., et al. 1980. Papulous photodependent mucinosis and disseminated lupus erythe-matosus. Ann. Dermatol. Venereol. 107, 1193.

Mutasim, D.F. 2003. Severe subacute cutaneous lupus erythe-matosus presenting with generalized erythroderma and bul-lae. J. Am. Acad. Dermatol. 48, 947.

Nagy, E., Balogh, E. 1961. Bullous form of chronic discoid lupus erythematodes accompanied by LE-cell symptoms. Dermatologica 122, 6.

Nagy, E., Meszaros, C., Daroczy, P. 1967. Mucinosis papulosa. Hautarzt. 18, 283.

Ng, P.P., Tan, S.H., Tan, T. 2002. Lupus erythematosus panniculitis: a clinicopathologic study. Int. J. Dermatol. 41, 488.

Nishikawa, T., Provost, T.T. 1991. Differences in clinical, sero-logic, and immunogenetic features of white versus Oriental anti-SS-A/Ro-positive patients. J. Am. Acad. Dermatol. 25, 563.

Norden, D., Weinberg, J.M., Schumacher, H.R., et al. 1993. Bilateral periorbital edema in systemic lupus erythematosus. J. Rheumatol. 20, 2158.

O'Loughlin, S., Schroeter, A.L., Jordon, R.E. 1978. Chronic urticaria-like lesions in systemic lupus erythematosus. A review of 12 cases. Arch. Dermatol. 114, 879.

Olansky, A.J., Briggaman, R.A., Gammon, W.R., et al. 1982. Bullous systemic lupus erythematosus. J. Am. Acad. Der-matol. 7, 511.

Ortiz, V.G., Krishnan, R.S., Chen, L.L., et al. 2004. Papulo-nodular mucinosis in systemic lupus erythematosus. Der-matol. Online J. 10, 16.

Pacheco, T.R., Spates, S.T., Lee, L.A. 2002. Unilateral tumid lupus erythematosus. Lupus 11, 388.

Parodi, A., Caproni, M., Cardinali, C., et al. 2000. Clinical, histological and immunopathological features of 58 patients with subacute cutaneous lupus erythematosus. A review by the Italian group of immunodermatology. Dermatology 200, 6.

Patel, P., Werth, V. 2002. Cutaneous lupus erythematosus: a review, Dermatol. Clin. 20, 373.

This article reviews information about the pathogenesis, clinical presentation, diagnosis, and treatment of CLE.

Penneys, N.S., Wiley, H.E. 1979. Herpetiform blisters in systemic lupus erythematosus. Arch. Dermatol. 115, 1427.

Perniciaro, C., Randle, H.W., Perry, H.O. 1995. Hypertrophic discoid lupus erythematosus resembling squamous cell carcinoma. J. Rheumatol. 21, 255.

Peters, M.S., Su, W.P. 1989. Lupus erythematosus panniculitis. Med. Clin. North Am. 73, 1113.

Pramatarov, K. 1998. Drug-induced lupus erythematosus. Clin. Dermatol. 16, 367.

Provost, T.T. 2004. Nonspecific cutaneous manifestations of systemic lupus erythematosus. In: A. Kuhn, P. Lehmann, T. Ruzicka (Eds.), Cutaneous Lupus Erythematosus. Springer, Heidelberg, p. 93.

Provost, T.T., Talal, N., Bias, W., et al. 1988a. Ro(SS-A) positive Sjogren's/lupus erythematosus (SC/LE) overlap patients are associated with the HLA-DR3 and/or DRw6 phenotypes. J. Invest. Dermatol. 91, 369.

Provost, T.T., Talal, N., Harley, J.B., et al. 1988b. The relationship between anti-Ro (SS-A) antibody-positive Sjog-ren's syndrome and anti-Ro (SS-A) antibody-positive lupus erythematosus. Arch. Dermatol. 124, 63.

Provost, T.T., Zone, J.J., Synkowski, D., et al. 1980. Unusual cutaneous manifestations of systemic lupus erythematosus:

I. Urticaria-like lesions. Correlation with clinical and serological abnormalities. J. Invest. Dermatol. 75, 495.

Prystowsky, S.D., Gilliam, J.M. 1975. Discoid lupus erythematosus as part of a larger disease spectrum. Correlation of clinical features with laboratory findings in lupus erythematosus. Arch. Dermatol. 111, 1448.

Rao, B., Coldiron, B., Freemann, R.G., et al. 1990. Subacute cutaneous lupus erythematosus lesions progressing morph-ea. J. Am. Acad. Dermatol. 23, 1019.

Reed, R.J., Clark, W.H., Mihm, M.C. 1973. The cutaneous mucinoses. Hum. Pathol. 4, 201.

Romero, R.W., Nesbitt, L.T.J., Reed, R.J. 1977. Unusual variant of lupus erythematosus or lichen planus. Clinical, his-topathologic, and immunofluorescent studies. Arch. Dermatol. 113, 741.

Rongioletti, F., Rebora, A. 1991. The new cutaneous mucinoses: a review with an up-to-date classification of cutaneous mucinoses. J. Am. Acad. Dermatol. 24, 265.

Rongioletti, F., Rebora, A. 2001. Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema. J. Am. Acad. Dermatol. 44, 273.

Rothfield, N.F. 1993. Lupus erythematosus. In: T.B. Fitzpatrick, A.Z. Eisen, K. Wolff, I.M. Freedberg, K.F. Austen (Eds.), Dermatology and General Medicine. McG-raw, New York, p. 2138.

Rowell, N.R. 1987. Chilblain lupus erythematosus responding to etretinate. Br. J. Dermatol. 117, 100.

Rowell, N.R., Swanson-Beck, J., Anderson, J.P. 1963. Lupus erythematosus and erythema multifirme-like lesions. Arch. Dermatol. 88, 176.

Rubin, R.L. 1999. Etiology and mechanisms of drug-induced lupus. Curr. Opin. Rheumatol. 11, 357.

Ruiz, H., Sanchez, J.L. 1999. Tumid lupus erythematosus. Am. J. Dermatopathol. 21, 356.

Ruzicka, T., Faes, J., Bergner, T., et al. 1991. Annular erythema associated with Sjogren's syndrome: a variant of systemic lupus erythematosus. J. Am. Acad. Dermatol. 25, 557.

Sanchez, N.P., Winkelmann, R.K., Schroeter, A.L. 1982. The clinical and histopathologic spectrums of urticarial vasculitis: study of forty cases. J. Am. Acad. Dermatol. 7, 599.

Sanchez-Perez, J., Fernandez-Herrera, J., Sols, M., et al. 1993. Leucocytoclastic vasculitis in subacute cutaneous lupus ery-thematosus. Br. J. Dermatol. 128, 469.

Shirahama, S., Furukawa, F., Yagi, H., et al. 1998. Bullous systemic lupus erythematosus: detection of antibodies against noncollagenous domain of type VII collagen. J. Am. Acad. Dermatol. 38, 844.

Sonntag, M., Lehmann, P., Megahed, M., et al. 2003. Papulo-nodular mucinosis associated with subacute cutaneous lupus erythematosus. Dermatology 206, 326.

Sontheimer, R.D. 1985a. Clinical significance of subacute cutaneous lupus erythematosus skin lesions. J. Dermatol. 12, 205.

Sontheimer, R.D. 1985b. Subacute cutaneous lupus erythe-matosus. Clin. Dermatol. 3, 58.

Sontheimer, R.D. 1989. Subacute cutaneous lupus erythematosus: a decade's perspective. Med. Clin. North Am. 73, 1073.

The clinical features of SCLE are summarized on its 10th anniversary and the results of published data are compared with unpublished experience in over 100 patients with this subtype.

Sontheimer, R.D. 1997. The lexicon of cutaneous lupus erythematosus—a review and personal perspective on the nomenclature and classification of the cutaneous manifestations of lupus erythematosus. Lupus 6, 84.

Sontheimer, R.D. 2000. Questions answered and a $1 million question raised concerning lupus erythematosus tumidus: is routine laboratory surveillance testing during treatment with hydroxychloroquine for skin disease really necessary. Arch. Dermatol. 136, 1044.

Sontheimer, R.D., Provost, T.T. 1996. Lupus erythematosus. In: R.D. Sontheimer, T.T. Provost (Eds.), Cutaneous Man-ifestatons of Rheumatic Diseases. Williams & Wilkins, Baltimore, p. 1.

Sontheimer, R.D., Thomas, JR., Gilliam, J.N. 1979. Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset. Arch. Dermatol. 115, 1409.

Su, W.P., Perniciaro, C., Rogers, R.S.R., et al. 1994. Chilblain lupus erythematosus (lupus pernio): clinical review of the Mayo Clinic experience and proposal of diagnostic criteria. Cutis 54, 395.

Tan, E.M., Cohen, A.S., Fries, J.F., et al. 1982. The 1982 revised criteria for the classification of systemic lupus erythe-matosus. Arthritis Rheum. 25, 1271.

Tebbe, B., Orfanos, C.E. 1997. Epidemiology and socioeconomic impact of skin disease in lupus erythematosus. Lupus 6, 96.

Tebbe, B., Mansmann, U., Wollina, U., et al. 1997. Markers in cutaneous lupus erythematosus indicating systemic involvement. A multicenter study on 296 patients. Acta Derm. Venereol. 77, 305.

Teramoto, N., Katayama, I., Arai, H., et al. 1989. Annular erythema: a possible association with primary Sjogren's syndrome. J. Am. Acad. Dermatol. 20, 596.

Tuffanelli, D.L. 1971. Lupus erythematosus panniculitis (profundus). Arch. Dermatol. 103, 231.

Ueki, H. 2005. Koebner phenomenon in lupus erythematosus with special consideration of clinical findings. Autoimmu-nity 4, 219.

Uter, W., Proksch, E., Schauder, S. 1988. Chilblain lupus ery-thematosus. Hautarzt 39, 602.

Uwatoko, S., Mannik, M. 1988. Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consists of autoantibodies to the collagenlike region of C1q. J. Clin. Invest. 82, 816.

Uy, H.S., Pineda, R., 2nd., Shore, J.W., et al. 1999. Hypertrophic discoid lupus erythematosus of the conjunctiva. Am. J. Ophthalmol. 127, 604.

Viguier, M., Pinquier, L., Cavelier-Balloy, B., et al. 2001. Clinical and histopathologic features and immunologic variables in patients with severe chilblains. A study of the relationship to lupus erythematosus. Medicine (Baltimore) 80, 180.

Vinciullo, C. 1986. Hypertrophic lupus erythematosus: differentiation from squamous cell carcinoma. Australas. J. Der-matol. 27, 76.

Watanabe, T., Tsuchida, T. 1995. Classification of lupus ery-thematosus based upon cutaneous manifestations. Derma-tological, systemic and laboratory findings in 191 patients. Dermatology 190, 277.

Watanabe, T., Tsuchida, T., Ito, Y., et al. 1997. Annular erythema associated with lupus erythematosus/Sjogren's syndrome. J. Am. Acad. Dermatol. 36, 214.

Wechsler, H.L., Stavrides, A. 1982. Systemic lupus erythemato-sus with anti-Ro antibodies: clinical, histologic and immu-nologic findings. Report of three cases. J. Am. Acad. Dermatol. 6, 73.

Weidner, F., Djawari, D. 1982. Mucinosis papulosa bei Lupus erythematodes integumentalis. Hautarztn 33, 286.

Weigand, D.A., Burgdorf, W.H., Gregg, L.J. 1981. Dermal mucinosis in discoid lupus erythematosus. Report of two cases. Arch. Dermatol. 117, 735.

Werth, V.P., White, W.L., Sanchez, M.R., et al. 1992. Incidence of alopecia areata in lupus erythematosus. Arch. Dermatol. 128, 368.

Wysenbeek, A.J., Block, D.A., Fries, J.F. 1989. Prevalence and expression of photosensitivity in systemic lupus erythemato-sus. Ann. Rheum. Dis. 48, 461.

Wysenbeek, A.J., Guedj, D., Amit, M., et al. 1992. Rash in systemic lupus erythematosus: prevalence and relation to cutaneous and non-cutaneus disease manifestations. Ann. Rheum. Dis. 51, 717.

Yell, J.A., Mbuagbaw, J., Burge, S.M. 1996. Cutaneous manifestations of systemic lupus erythematosus. Br. J. Der-matol. 135, 355.

Yell, J.A., Wojnarowska, F. 1997. Bullous skin disease in lupus erythematosus. Lupus 6, 112.

A number of bullous and vesicular skin lesions that are encountered in patients with LE are described and classified in this article.

Yung, A., Oakley, A. 2000. Bullous systemic lupus erythemato-sus. Australas. J. Dermatol. 41, 234.

Handbook of Systemic Autoimmune Diseases, Volume 5 The Skin in Systemic Autoimmune Diseases

Piercarlo Sarzi-Puttini, Andrea Doria, Giampiero Girolomoni and Annegret Kuhn, editors

Was this article helpful?

0 0
Natural Arthritis Pain Remedies

Natural Arthritis Pain Remedies

It's time for a change. Finally A Way to Get Pain Relief for Your Arthritis Without Possibly Risking Your Health in the Process. You may not be aware of this, but taking prescription drugs to get relief for your Arthritis Pain is not the only solution. There are alternative pain relief treatments available.

Get My Free Ebook

Post a comment